Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme
- Name
- Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme
- Accession Number
- DBCAT003279
- Description
Not Available
- Drugs
Drug Drug Description Agalsidase beta A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide. Agalsidase alfa A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide. - Drugs & Drug Targets
Drug Target Type Agalsidase beta Globotriaosylceramide target Agalsidase beta Cation-dependent mannose-6-phosphate receptor transporter Agalsidase alfa Cation-dependent mannose-6-phosphate receptor transporter Agalsidase alfa Globotriaosylceramide target